Stay updated with breaking news from Donald xu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aurealis Therapeutics, (Basel, Switzerland) and AI-based microbiome drug development company Xbiome have entered into an agreement for the clinical development and commercialisation of Aurealis’ investigational Diabetic Foot Ulcer (DFU) and other chronic wounds and inflammatory disease therapy in the Greater China territory. Click to read more. ....
/PRNewswire/ Aurealis Therapeutics, a synthetic biology company developing groundbreaking four-in-one cell and gene therapies and Xbiome, an AI-based. ....
AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China
GlobeNewswire
December 22, 2021
Frontier Biotechnologies obtains exclusive rights to develop and commercialize AFFITOPE® AT04 in Greater China Collaboration accelerates the global development of AFFiRiS potential first-in-class active immunotherapy with plans to. ....